Table 4.
IBD Patients n = 77 (43.3%) |
Control Group n = 101 (56.7%) |
Differences between Correlations |
|||
---|---|---|---|---|---|
Correlation Estimate (95% CI) | p-Value | Correlation Estimate (95% CI) | p-Value | p-Value | |
I am vaccinated against COVID-19 | 0.16 (−0.06 to 0.38) | 0.1603 | −0.27 (−0.27 to −0.08) | 0.0057 | 0.002 |
Vaccines can prevent severe illness | 0.60 (0.43 to 0.73) | <0.0001 | 0.43 (0.25 to 0.58) | <0.0001 | 0.07 |
COVID-19 vaccination will make the pandemic end sooner | 0.73 (0.60 to 0.83) | <0.0001 | 0.64 (0.50 to 0.75) | <0.0001 | 0.135 |
I believe in COVID-19 vaccine effectiveness | 0.77 (0.65 to 0.85) | <0.0001 | 0.69 (0.57 to 0.78) | <0.0001 | 0.153 |
I’m concerned about the safety of COVID-19 vaccination in IBD | −0.28 (−0.48 to −0.04) | 0.0202 | |||
COVID-19 vaccination may trigger IBD flares | −0.28 (−0.48 to −0.04) | 0.0192 | |||
Type of IBD | 0.07 (−0.16 to−0.30) | 0.5479 | |||
CD location | 0.28 (−0.05 to 0.56) | 0.0962 | |||
UC extension | −0.15 (−0.46 to 0.19) | 0.3902 | |||
Years of disease | 0.12 (−0.11 to 0.35) | 0.2967 | |||
IBD activity | −0.13 (−0.36 to 0.09) | 0.2475 | |||
Treatment | 0.08 (−0.15 to 0.31) | 0.4985 |